Lantheus Holdings, Inc.
LNTHAPI behind this page
LNTH Q1 2026 request
Playground key active
/api/financials?ticker=LNTH&year=2026&quarter=1
Pick an endpoint and run the request.Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue | 377,333 | 372,764 | +1.2% |
Show Product Lines breakouts |
|||
| DEFINITY | 84,627 | 79,211 | +6.8% |
| License and royalty revenues | 7,484 | 5,846 | +28.0% |
| Neuraceq | 35,439 | — | — |
| Product | 369,849 | 366,918 | +0.8% |
| PYLARIFY | 240,924 | 257,654 | -6.5% |
| Strategic partnerships and other revenue | 16,343 | 10,747 | +52.1% |
| Total cardiology | 84,627 | 79,211 | +6.8% |
| Total neurology | 35,439 | — | — |
| Total oncology | 240,924 | 257,654 | -6.5% |
Show Geography breakouts |
|||
| Non Us | 22,908 | 15,009 | +52.6% |
| US | 354,425 | 357,755 | -0.9% |
| Cost of Revenue | 146,411 | 135,064 | +8.4% |
| Gross Profit | 230,922 | 237,700 | -2.9% |
| Sales & Marketing | 52,684 | 42,503 | +24.0% |
| General & Administrative | 57,533 | 56,816 | +1.3% |
| Research & Development | 39,379 | 36,314 | +8.4% |
Show Business Segments breakouts |
|||
| Reportable Segment | 39,379 | 36,314 | +8.4% |
| Operating Expenses Before Gain Loss On Sale Of Assets | 149,596 | 135,633 | +10.3% |
| Operating Income | 81,326 | 102,067 | -20.3% |
| Interest Expense | 4,864 | 4,804 | +1.2% |
| Equity Securities Fv Ni Gain Loss | -14,905 | 14,862 | -200.3% |
| Disposal Group Not Discontinued Operation Gain Loss On Disposal | -59,328 | — | — |
| Other Non-Operating Income (Expense) | -5,710 | -14,128 | +59.6% |
| Income Before Taxes | 156,405 | 96,529 | +62.0% |
| Income Tax Expense (Benefit) | 37,988 | 23,584 | +61.1% |
| Net Income | 118,417 | 72,945 | +62.3% |
Show Equity Components breakouts |
|||
| Retained Earnings | 118,417 | 72,945 | +62.3% |
| EPS (Basic) | 1.83 | 1.06 | +72.6% |
| EPS (Diluted) | 1.8 | 1.02 | +76.5% |
| Wtd Avg Shares (Basic) | 64,736 | 68,675 | -5.7% |
| Wtd Avg Shares (Diluted) | 65,772 | 71,461 | -8.0% |
| Comprehensive Income | 117,857 | 72,802 | +61.9% |
| Other Comprehensive Income | -560 | -143 | -291.6% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -560 | -143 | -291.6% |
| Foreign Currency Transaction Gain Loss Before Tax | -1,203 | 78 | -1642.3% |
| Net Income Loss Available To Common Stockholders Basic | 118,417 | 72,945 | +62.3% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 498,582 | 938,533 | -46.9% |
| Accounts Receivable | 355,666 | 348,749 | +2.0% |
| Inventory | 61,339 | — | — |
| Income Taxes Receivable | 1,487 | — | — |
| Other Assets Current | 25,214 | 67,372 | -62.6% |
| Total Current Assets | 942,288 | 1,423,780 | -33.8% |
| Non-Current Assets | |||
| Notes And Loans Receivable Net Noncurrent | 92,103 | — | — |
| Goodwill | 239,399 | — | — |
| Deferred Tax Assets | 89,122 | 168,885 | -47.2% |
| Other Non-Current Assets | 61,742 | 36,467 | +69.3% |
| Total Assets | 2,346,587 | 2,055,224 | +14.2% |
| Property, Plant & Equipment | 157,563 | 180,783 | -12.8% |
| Intangible Assets | 457,058 | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Currently marketed products | 397,526 | — | — |
| Customer Relationships | 9,922 | — | — |
| Developed Technology Rights | 40,791 | — | — |
| Licensing Agreements | 7,825 | — | — |
| Trademarks | 994 | — | — |
| Other Assets | |||
| Equity Securities Fv Ni And Without Readily Determinable Fair Value | 58,312 | 30,375 | +92.0% |
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 157,563 | 180,783 | -12.8% |
| Intangible Assets Net Excluding Goodwill | 706,058 | — | — |
| Current Liabilities | |||
| Current Portion of Long-Term Debt | 803 | 747 | +7.5% |
| Accounts Payable | 45,875 | 44,874 | +2.2% |
| Accounts Payable And Other Accrued Liabilities Current | 286,488 | — | — |
| Total Current Liabilities | 333,166 | 248,002 | +34.3% |
| Non-Current Liabilities | |||
| Asset Retirement Obligations Noncurrent | 139 | 18,740 | -99.3% |
| Deferred Tax Liabilities | 53,508 | — | — |
| Business Combination Contingent Consideration Liability Noncurrent | 72,647 | — | — |
| Other Non-Current Liabilities | 105,235 | — | — |
| Total Liabilities | 1,134,299 | 891,030 | +27.3% |
| Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| 2.625% Convertible Senior Notes due December 2027 · Convertible Debt | 575 | — | — |
| Operating Lease Liabilities | 55,345 | — | — |
| Other Liabilities | |||
| Long Term Debt And Capital Lease Obligations | 569,604 | — | — |
| Stockholders' Equity | |||
| Common Stock | 723 | 716 | +1.0% |
| Additional Paid In Capital Common Stock | 892,949 | 821,346 | +8.7% |
| Treasury Stock Common Value | -477,438 | -175,000 | -172.8% |
| Retained Earnings | 797,921 | 518,890 | +53.8% |
| Accumulated Other Comprehensive Income | -1,867 | -1,758 | -6.2% |
| Total Stockholders' Equity | 1,212,288 | 1,164,194 | +4.1% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -1,867 | -1,758 | -6.2% |
| Additional Paid In Capital | 892,949 | 821,346 | +8.7% |
| Common Stock | 723 | 716 | +1.0% |
| Retained Earnings | 797,921 | 518,890 | +53.8% |
| Treasury Stock Common | -477,438 | -175,000 | -172.8% |
| Total Liabilities & Equity | 2,346,587 | 2,055,224 | +14.2% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation Amortization And Accretion Net | 22,683 | 13,626 | +66.5% |
| Amortization of Financing Costs | 1,115 | 1,115 | 0.0% |
| Change In Fair Value Of Contingent Assets And Liabilities | -358 | — | — |
| Inventory Write Down | 1,537 | -1,378 | +211.5% |
| Stock-Based Compensation | 16,041 | 21,198 | -24.3% |
| Equity Securities Fv Ni Unrealized Gain Loss | -14,905 | 14,862 | -200.3% |
| Noncash Itemsto Reconcile Net Income Lossto Cash Providedby Usedin Operating Activities Deferred Income Tax Expense Benefit | 19,327 | 1,351 | +1330.6% |
| Change in Other Liabilities | 84 | 639 | -86.9% |
| Gain Loss On Sale Of Business | -59,328 | — | — |
| Other Non-Cash Items | -2,317 | 822 | -381.9% |
| Change in Accounts Receivable | -2,232 | -26,363 | +91.5% |
| Change in Inventory | 2,113 | 278 | +660.1% |
| Increase Decrease In Other Operating Assets | -244 | -528 | +53.8% |
| Change in Accounts Payable | 190 | 4,982 | -96.2% |
| Increase Decrease In Accrued Liabilities | 23,004 | 3,328 | +591.2% |
| Net Cash from Operations | 125,127 | 107,563 | +16.3% |
| Investing Activities | |||
| Payments For Capital Improvements | -3,226 | -8,718 | +63.0% |
| Proceeds From Divestiture Of Businesses | 24,212 | — | — |
| Proceeds From Sale Of Productive Assets | 5,000 | — | — |
| Net Cash from Investing | 25,986 | -63,718 | +140.8% |
| Lease Modification | 1,939 | 5,789 | -66.5% |
| Notes Issued1 | 94,000 | — | — |
| Contingent Consideration Assets Related To Sale Of Business | 6,500 | — | — |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 4,822 | — | — |
| Right Of Use Asset Obtained In Exchange For Finance Lease Liability | 316 | 150 | +110.7% |
| Financing Activities | |||
| Repayments Of Long Term Debt | -216 | -402 | +46.3% |
| Proceeds From Stock Options Exercised | 1,697 | 3,886 | -56.3% |
| Proceeds From Stock Plans | 2,591 | — | — |
| Tax Withholding for Share Compensation | -15,695 | -23,686 | +33.7% |
| Net Cash from Financing | -11,623 | -18,219 | +36.2% |
| Supplemental | |||
| Unpaid Capital Expenditures | 2,036 | 5,855 | -65.2% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -22 | 102 | -121.6% |
| Net Change in Cash | 139,468 | 25,728 | +442.1% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 500,294 | 940,214 | -46.8% |
| Restricted Cash And Cash Equivalents | 1,712 | 1,681 | +1.8% |
Values in thousands USD. Source: SEC EDGAR 10-Q filing.